Cost-Effectiveness of Dual-Chamber Pacing Compared With Ventricular Pacing for Sinus Node Dysfunction
暂无分享,去创建一个
L. Goldman | G. Lamas | M. Weinstein | E. Schron | D. Cohen | S. Rinfret | K. Fleischmann | J. Orav | Kerry L Lee | D. Cohen
[1] A. Waldo. Cost-Effectiveness of Dual-Chamber Pacing Compared With Ventricular Pacing for Sinus Node DysfunctionRinfret S, Chen DJ, Lamas GA, et al (Univ of Montreal, Canada; Harvard Med School, Boston; Miami Heart Inst, Miami Beach, Fla; et al) Circulation 111:165-172, 2005§ , 2006 .
[2] L. Goldman,et al. High incidence of pacemaker syndrome in patients with sinus node dysfunction treated with ventricular-based pacing in the Mode Selection Trial (MOST). , 2004, Journal of the American College of Cardiology.
[3] L. Goldman,et al. Predictors and Clinical Impact of Atrial Fibrillation After Pacemaker Implantation in Elderly Patients Treated with Dual Chamber Versus Ventricular Pacing , 2003, Pacing and clinical electrophysiology : PACE.
[4] G. Lamas,et al. Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction , 2003, Circulation.
[5] G. Lamas,et al. Pacemaker Mode Selection: , 2003 .
[6] G. Lamas,et al. Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke: Report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST) , 2003, Circulation.
[7] S. Connolly,et al. Effect of pacing mode on health-related quality of life in the Canadian Trial of Physiologic Pacing. , 2003, American heart journal.
[8] G. Lamas,et al. Pacemaker mode selection: the evidence from randomized trials. , 2003, Pacing and clinical electrophysiology : PACE.
[9] R. Kerber,et al. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices , 2002 .
[10] R. Kerber,et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). , 2002, Circulation.
[11] K. McDonald,et al. Effectiveness and cost-effectiveness of implantable cardioverter defibrillators in the treatment of ventricular arrhythmias among medicare beneficiaries. , 2002, The American journal of medicine.
[12] L. Goldman,et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. , 2002, The New England journal of medicine.
[13] G. Larsen,et al. Cost-Effectiveness of the Implantable Cardioverter-Defibrillator Versus Antiarrhythmic Drugs in Survivors of Serious Ventricular Tachyarrhythmias: Results of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Economic Analysis Substudy , 2002, Circulation.
[14] C. Cannon,et al. Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction. , 2002, JAMA.
[15] M Gent,et al. Effect of Clinical Risk Stratification on Cost-Effectiveness of the Implantable Cardioverter-Defibrillator: The Canadian Implantable Defibrillator Study , 2001, Circulation.
[16] S. Connolly,et al. Progression to chronic atrial fibrillation after pacing: the Canadian Trial of Physiologic Pacing. CTOPP Investigators. , 2001, Journal of the American College of Cardiology.
[17] J. Gardiner,et al. The effect of outliers on confidence interval procedures for cost‐effectiveness ratios , 2001, Statistics in medicine.
[18] B. Schwaab,et al. Longevity of Dual Chamber Pacemakers: Device and Patient Related Determinants , 2001, Pacing and clinical electrophysiology : PACE.
[19] M Gent,et al. Cost-Effectiveness of the Implantable Cardioverter-Defibrillator: Results From the Canadian Implantable Defibrillator Study (CIDS) , 2001, Circulation.
[20] M Gent,et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes , 2000 .
[21] T. Nielsen,et al. Regional myocardial blood flow in patients with sick sinus syndrome randomized to long-term single chamber atrial or dual chamber pacing--effect of pacing mode and rate. , 2000, Journal of the American College of Cardiology.
[22] B A Craig,et al. Uncertainty in Decision Models Analyzing Cost-Effectiveness , 2000, Medical decision making : an international journal of the Society for Medical Decision Making.
[23] A I Mushlin,et al. The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Multicenter Automatic Defibrillator Implantation Trial. , 1998, Circulation.
[24] L. Goldman,et al. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. , 1998, Pacing and clinical electrophysiology : PACE.
[25] L. Thuesen,et al. Heart failure and echocardiographic changes during long-term follow-up of patients with sick sinus syndrome randomized to single-chamber atrial or ventricular pacing. , 1998, Circulation.
[26] L. Thuesen,et al. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome , 1997, The Lancet.
[27] M. Gold. Cost-effectiveness in health and medicine , 2016 .
[28] M. Weinstein,et al. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. , 1996, JAMA.
[29] A. Gillis,et al. The Impact of Pulse Generator Longevity on the Long‐Term Costs of Cardiac Pacing , 1996, Pacing and clinical electrophysiology : PACE.
[30] Erry,et al. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. , 1995, The New England journal of medicine.
[31] L. Goldman,et al. Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease. Use of a decision-analytic model. , 1994, Circulation.
[32] J R Beck,et al. Markov Models in Medical Decision Making , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.
[33] F A Sonnenberg,et al. Commentary: Fine-tuning Life-espectancy Calculations Using Markov Processes , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.
[34] E. Sowton,et al. "Subclinical" pacemaker syndrome: a randomised study of symptom free patients with ventricular demand (VVI) pacemakers upgraded to dual chamber devices. , 1992, British heart journal.
[35] M. Rosenqvist,et al. Relative importance of activation sequence compared to atrioventricular synchrony in left ventricular function. , 1991, The American journal of cardiology.
[36] E F Cook,et al. Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction. , 1988, The New England journal of medicine.
[37] S. Kaplan. Patient reports of health status as predictors of physiologic health measures in chronic disease. , 1987, Journal of chronic diseases.
[38] D. Singer,et al. Single-chamber and dual-chamber cardiac pacemakers. A formal cost comparison. , 1986, Annals of internal medicine.
[39] Joseph S. Pliskin,et al. Utility Functions for Life Years and Health Status , 1980, Oper. Res..